Rhumbline Advisers »

Cytek Biosciences shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 295k 5.54
2024-06-30 $2.0M 355k 5.58
2024-03-31 $2.3M 337k 6.71
2023-12-31 $3.0M 328k 9.12
2023-09-30 $1.8M 322k 5.52
2023-06-30 $2.5M 290k 8.54
2023-03-31 $1.4M 149k 9.19
2022-12-31 $1.5M 143k 10.21
2022-09-30 $2.1M 141k 14.72
2022-06-30 $1.4M 129k 10.73
2022-03-31 $1.0M 96k 10.78
2021-12-31 $242k 15k 16.33
2021-09-30 $252k 12k 21.43